Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
31.52
+1.11 (3.63%)
Jun 26, 2026, 2:15 PM EDT - Market open
Neurogene Market Cap
Neurogene has a market cap or net worth of $498 million as of June 26, 2026. Its market cap has increased by 66.91% in one year.
Market Cap
498.00M
Enterprise Value
246.48M
1-Year Change
66.91%
Ranking
Category
Stock Price
$31.52
Market Cap Chart
Since December 19, 2023, Neurogene's market cap has increased from $193.64M to $498.00M, an increase of 157.18%. That is a compound annual growth rate of 45.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 498.00M | 56.07% |
| Dec 31, 2025 | 319.09M | -6.03% |
| Dec 31, 2024 | 339.58M | 36.64% |
| Dec 29, 2023 | 248.52M | 28.34% |
| Dec 19, 2023 | 193.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kyverna Therapeutics | 498.52M |
| Contineum Therapeutics | 496.86M |
| Sutro Biopharma | 489.66M |
| C4 Therapeutics | 486.50M |
| Prothena Corporation | 485.31M |
| Assembly Biosciences | 480.77M |
| Cabaletta Bio | 476.12M |
| Valneva SE | 474.76M |